S Saarikoski
Overview
Explore the profile of S Saarikoski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
238
Citations
1868
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Timonen H, Myllari F, Simonen P, Aurela M, Maasikmets M, Bloss M, et al.
J Environ Manage
. 2021 May;
293:112793.
PMID: 34058452
In households, municipal solid waste (MSW) is often burned along with wood to get rid of waste, to help in ignition or simply to reduce fuel costs. The aim of...
2.
Sillanpaa S, Anttila M, Suhonen K, Hamalainen K, Turpeenniemi-Hujanen T, Puistola U, et al.
Tumour Biol
. 2007 Oct;
28(5):280-9.
PMID: 17962725
Aims: We investigated the prognostic significance of extracellular matrix metalloproteinase inducer (EMMPRIN) and matrix metalloproteinase 2 (MMP-2) in epithelial ovarian cancer as well as their relation to hyaluronan (HA) expression....
3.
Sillanpaa S, Anttila M, Voutilainen K, Ropponen K, Turpeenniemi-Hujanen T, Puistola U, et al.
Gynecol Oncol
. 2006 Oct;
104(2):296-303.
PMID: 17034838
Objective: We investigated the expression of matrix metalloproteinase-9 (MMP-9) and its relation to clinicopathologic factors and survival and also to previously analyzed expressions of CD44 and hyaluronan in epithelial ovarian...
4.
Toivonen S, Keski-Nisula L, Saarikoski S, Heinonen S
Clin Genet
. 2004 Aug;
66(3):244-6.
PMID: 15324325
No abstract available.
5.
Heinonen S, Tyrvainen E, Saarikoski S, Ruokonen E
Int J Obstet Anesth
. 2004 Aug;
11(4):260-4.
PMID: 15321532
The purpose of this study was to note potential obstetric risk factors leading to maternal intensive care and to estimate the frequency, costs and outcomes of management. In a cross-sectional...
6.
Kantola M, Purkunen R, Kroger P, Tooming A, Juravskaja J, Pasanen M, et al.
Environ Res
. 2004 Jul;
96(1):51-61.
PMID: 15261784
Transportation of selenium from mother to fetus and its possible effects on mother's zinc, copper, cadmium, and mercury levels were studied together during the first trimester and at term in...
7.
Huopio J, Kroger H, Honkanen R, Jurvelin J, Saarikoski S, Alhava E
Osteoporos Int
. 2004 Jan;
15(3):190-5.
PMID: 14727012
Low calcaneal ultrasound measurement (quantitative ultrasound, QUS) has been shown to predict fractures in elderly women. However, only a few studies have examined its ability to predict perimenopausal and early...
8.
Juntunen M, Niskanen L, Saarelainen J, Tuppurainen M, Saarikoski S, Honkanen R
J Hum Hypertens
. 2003 Oct;
17(11):775-9.
PMID: 14578917
We assessed the determinants of onset of hypertension in a large, prospective population-based study of perimenopausal women from the Kuopio Osteoporosis Risk Factor and Prevention (OSTPRE) study. The data collection...
9.
Sirola J, Kroger H, Sandini L, Tuppurainen M, Jurvelin J, Saarikoski S, et al.
Calcif Tissue Int
. 2003 Oct;
72(6):659-65.
PMID: 14562993
The aim of this study was to investigate the interactive effects between nutritional calcium (Ca) intake and hormone replacement therapy (HRT) on bone loss. The study population, 937 peri- and...
10.
Sirola J, Kroger H, Honkanen R, Sandini L, Tuppurainen M, Jurvelin J, et al.
Osteoporos Int
. 2003 Feb;
14(1):27-33.
PMID: 12577182
In the present study we evaluated the risk factors associated with peri- and postmenopausal bone loss and the effect of hormone replacement therapy (HRT) on weight-loss-related bone loss. The study...